Announcements Trials

Browse Landscape

Status

Active not recruiting 6 Recruiting 5 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

pembrolizumab 112 Carboplatin 47 Nivolumab 41 Paclitaxel 34 Cyclophosphamide 32 Cisplatin 32 Gemcitabine 30 atezolizumab 28 venetoclax 25 Specimen Handling 24 Pemetrexed 24 Magnetic Resonance Spectroscopy 24 fludarabine 22 Docetaxel 22 Biopsy 22 Bevacizumab 22 Azacitidine 22 Radiotherapy 21 Ipilimumab 21 Radiosurgery 18 Fluorouracil 18 durvalumab 17 Dexamethasone 17 Cetuximab 17 fludarabine phosphate 14 Trastuzumab 14 Leucovorin 14 Radiation 13 Injections 13 Cytarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Biopsy, Large-Core Needle × 1 year × Clear all

NCT05435352 2025-07-30

PEAR-TNBC

Ourotech, Inc.

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡